https://www.fhcrc.org/en/news/releases/rss2014-02-24T20:37:52.752ZNews Releases RSS FeedAdobe Experience ManagerEarly detection helps manage a chronic graft-vs.-host disease complication - Fred Hutchinson Cancer Research CenterA simple questionnaire that rates breathing difficulties on a scale of 0 to 3 predicts survival in chronic graft-vs.-host disease, according to a study published in the March issue of Biology of Blood and Marrow Transplantation.https://www.fhcrc.org/en/news/releases/2014/03/early-detection-chronic-graft-vs-host-disease2014-03-06T21:17:35.000Z2014-03-06T21:17:35.000ZShop and dine to help fund women’s cancer research at Fred Hutch - Fred Hutchinson Cancer Research CenterShop & Dine to Make a Difference, now in its 11th year, lets shoppers and diners score deals at University Village while helping support women’s cancer research at Fred Hutchinson Cancer Research Center.https://www.fhcrc.org/en/news/releases/2014/02/shop-and-dine-to-help-fund-womens-cancer-research-at-fred-hutch2014-02-25T22:11:29.000Z2014-02-25T22:11:29.000ZFred Hutch, SCCA researchers receive Leaders in Health Care Awards - Fred Hutchinson Cancer Research CenterResearchers at Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) were recognized in several categories of Seattle Business Magazine’s 2014 Leaders in Health Care Awards, including the publication’s Lifetime Achievement Award, given to Frederick R. Appelbaum, M.D., executive vice president and deputy director of Fred Hutch and president of SCCA.
The awards honor individuals and organizations in Washington’s health care industry who have made significant contributions to health and well-being. The awards were presented February 24 at the Seattle Business Leaders in Health Care Awards ceremony held at Seattle’s Washington State Convention Center.https://www.fhcrc.org/en/news/releases/2014/02/fred-hutch-scca-researchers-receive-leaders-in-health-care-awards2014-02-25T18:43:28.000Z2014-02-25T18:43:28.000ZSelenium and vitamin E supplements can increase risk of prostate cancer in some men - Fred Hutchinson Cancer Research CenterA multi-center study led by Fred Hutchinson Cancer Research Center has found that high-dose supplementation with both the trace element selenium and vitamin E increase the risk of high-grade prostate cancer. But importantly, this risk depends upon a man’s selenium status before taking the supplements.https://www.fhcrc.org/en/news/releases/2014/02/selenium-and-vitamin-e-supplements-can-increase-risk-of-prostate-cancer-in-some-men2014-02-21T21:44:15.000Z2014-02-21T21:44:15.000ZDismantling pancreas cancer’s armor - Fred Hutchinson Cancer Research CenterPancreas cancer is notoriously impervious to treatment and resists both chemotherapy and radiotherapy. It has also been thought to provide few targets for immune cells, allowing tumors to grow unchecked. But new research from Fred Hutchinson Cancer Research Center shows that pancreas cancer “veils” itself from the immune system by recruiting specialized immune suppressor cells. The research team also found that removing these cells quickly triggers a spontaneous anti-tumor immune response. https://www.fhcrc.org/en/news/releases/2014/02/dismantling-pancreas-cancers-armor2014-02-20T17:21:39.000Z2014-02-20T17:21:39.000ZNew drug shows promise in treating indolent non-Hodgkin lymphomas - Fred Hutchinson Cancer Research CenterSEATTLE – Slow-growing, or indolent, non-Hodgkin lymphomas are difficult to treat, with most patients relapsing repeatedly and the disease becoming increasingly resistant to therapy over time.
But a new drug made by Seattle-based Gilead Sciences Inc. appears to offer hope for fighting the disease, according to a study published online today in The New England Journal of Medicine in advance of its March 13 print issue.https://www.fhcrc.org/en/news/releases/2014/01/new-drug-shows-promise-in-treating-indolent-non-hodgkin-lymphomas2014-01-22T22:00:00.000Z2014-01-22T22:00:00.000ZFred Hutch, SCCA receive CEO Cancer Gold Standard accreditation - Fred Hutchinson Cancer Research CenterFred Hutchinson Cancer Research Center and its cancer treatment arm, Seattle Cancer Care Alliance (SCCA), each have earned CEO Cancer Gold Standard accreditation in recognition of their commitment to employee health.CEO Cancer Gold Standard accreditation calls for companies to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. https://www.fhcrc.org/en/news/releases/2014/01/fred-hutch-scca-receive-ceo-cancer-gold-standard-accreditation2014-01-14T22:18:22.000Z2014-01-14T22:18:22.000ZResearchers develop tool to determine individual risk of prostate cancer overdiagnosis - Fred Hutchinson Cancer Research CenterStudies have found that prostate cancer is overdiagnosed in up to 42 percent of cases, prompting men to receive unnecessary treatment that can cause devastating side effects, including impotence and incontinence.https://www.fhcrc.org/en/news/releases/2014/01/researchers-develop-tool-to-determine-individual-risk-of-prostate-cancer-overdiagnosis2014-01-09T21:50:51.000Z2014-01-09T21:50:51.000ZGary Lyman of Duke University and Cancer Institute to co-lead Hutchinson Institute for Cancer Outcomes Research at Fred Hutchinson Cancer Research Center - Fred Hutchinson Cancer Research CenterThe Hutchinson Institute for Cancer Outcomes Research (HICOR), an innovative research institute based at Fred Hutchinson Cancer Research Center that is charged with evaluating and improving the effectiveness and value of cancer prevention and treatment strategies through collaborative research – including health-economic analyses – has hired Gary Lyman, M.D., M.P.H., of Duke University to serve as the Institute’s co-director.https://www.fhcrc.org/en/news/releases/2014/01/gary-lyman-of-duke-university-and-cancer-institute-to-co-lead-hutchinson-institute-for-cancer-outcomes-research-at-fred-hutchinson-cancer-research-center2014-01-08T18:21:01.000Z2014-01-08T18:21:01.000Z8 million lives saved over 50 years, study finds - Fred Hutchinson Cancer Research Centerhttps://www.fhcrc.org/en/news/releases/2014/01/eight-million-lives-saved-over-50-years-study-finds2014-01-07T21:00:00.000Z2014-01-07T21:00:00.000ZObliteride 2014 debuts with new routes and new ways to help end cancer - Fred Hutchinson Cancer Research CenterAfter a hugely successful and fun inaugural Obliteride 2013, Fred Hutchinson Cancer Research Center is gearing up for the second annual community fundraising bike ride to raise money to help end cancer. Rider registration for the Aug. 8-10, 2014 event opens today at Obliteride.org. Register early to hold your spot in Obliteride 2014.https://www.fhcrc.org/en/news/releases/2014/01/obliteride-2014-debuts-with-new-routes-and-new-ways-to-help-end-cancer2014-01-06T08:00:00.000Z2014-01-06T08:00:00.000ZHIV Vaccine Trials Network among five nationwide selected to receive seven-year award - Fred Hutchinson Cancer Research CenterThe HIV Vaccine Trials Network, based at Fred Hutchinson Cancer Research Center, is among five clinical trial networks across the United States that will receive substantial federal funding to continue their work in the fight against HIV/AIDS.
The National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health, announced yesterday that it will fund the five networks for a seven-year cycle starting in 2014. Total funding is expected to reach $225 million next year. https://www.fhcrc.org/en/news/releases/2013/12/hiv-vaccine-trials-network-among-five-nationwide-selected-to-receive-seven-year-award2013-12-17T22:39:24.000Z2013-12-17T22:39:24.000ZGame It Forward's "Quingo" game for charity decked for the holidays"Quingo,” a game launched in September by local startup Game It Forward for the iPhone, iPad and iPod Touch, today, just in time for the holidays, released a new “Winter Wonderland” question pack. https://www.fhcrc.org/en/news/releases/2013/12/Quingo-holiday2013-12-13T16:33:00.000Z2013-12-13T16:33:00.000ZInternational study demonstrates protein-measurement technique’s potential to standardize quantification of the entire human proteome - Fred Hutchinson Cancer Research CenterAn international team of scientists led by Fred Hutchinson Cancer Research Center cancer proteomics expert Amanda Paulovich, M.D., has demonstrated the feasibility of large-scale, standardized protein measurements, which are necessary for validation of disease biomarkers and drug targets. https://www.fhcrc.org/en/news/releases/2013/12/international-study-demonstrates-protein-measurement-techniques-potential-to-standardize-quantification-of-the-entire-human-proteome2013-12-08T22:30:00.000Z2013-12-08T22:30:00.000ZPredicting ovarian cancer by counting tumor-attacking immune cellsFred Hutch scientists have developed a new method for counting a special class of cancer-fighting cells – called tumor-infiltrating T lymphocytes, or TILs – reliably, quickly and cheaply in patients with early stage and advanced ovarian cancer. https://www.fhcrc.org/en/news/releases/2013/11/ovarian-cancer-immune-cells2013-12-04T22:02:16.000Z2013-12-04T22:02:16.000ZLeading cancer research centers team up to launch biotech startup focused on cancer immunotherapyThe Fred Hutchinson Cancer Research Center and Memorial Sloan-Kettering Cancer Center, along with pediatric partner Seattle Children’s Research Institute, have joined forces to launch Juno Therapeutics Inc., a new biotechnology company focused on bringing forward novel immunotherapies for cancer.https://www.fhcrc.org/en/news/releases/2013/11/biotech-startup-cancer-immunotherapy2013-12-04T21:44:09.000Z2013-12-04T21:44:09.000ZNew insights into cancer evolution help define screening window of opportunityNew insights into cancer evolution help define screening window of opportunity A new appreciation of the genetic changes that occur as precancerous cells turn malignant could help researchers design new screening strategies
https://www.fhcrc.org/en/news/releases/2013/11/cancer-evolution-define-screening2013-12-03T18:41:08.000Z2013-12-03T18:41:08.000ZStudy finds link between allergies and increased risk of blood cancers in women - Fred Hutchinson Cancer Research CenterA team of scientists looking into the interplay of the immune system and cancer have found a link between a history of airborne allergies – in particular to plants, grass and trees – with risk of blood cancers in women. Notably, the study did not find the same association in men, which suggests a possible gender-specific role in chronic stimulation of the immune system that may lead to the development of hematologic cancers.
https://www.fhcrc.org/en/news/releases/2013/11/study-finds-link-between-allergies-and-increased-risk-of-blood-cancers-in-women2013-11-22T05:00:00.000Z2013-11-22T05:00:00.000ZHIV vaccine researcher Julie McElrath receives Women of Influence Award - Fred Hutchinson Cancer Research CenterJulie McElrath, M.D., Ph.D., an HIV vaccine researcher at Fred Hutchinson Cancer Research Center, is among 16 recipients of Puget Sound Business Journal’s 2013 Women of Influence Award. She accepted the honor last night at an award ceremony at the Hyatt Regency in Bellevue, Wash.https://www.fhcrc.org/en/news/releases/2013/11/hiv-vaccine-researcher-julie-mcelrath-receives-women-of-influence-award2013-11-14T08:00:00.000Z2013-11-14T08:00:00.000ZSeattle Mariners outfielder/designated hitter Raúl Ibañez named Hutch Award® winner - Fred Hutchinson Cancer Research CenterRaúl Ibañez, an outfielder and designated hitter for the Seattle Mariners who is considered one of the most consistent and professional players in Major League Baseball, will receive the 49th annual Hutch Award® at a Jan. 30 luncheon at Seattle’s Safeco Field.https://www.fhcrc.org/en/news/releases/2013/11/seattle-mariners-outfielder-designated-hitter-raul-ibanez-named-hutch-award-winner2013-11-05T17:50:17.000Z2013-11-05T17:50:17.000Z